Somatostatin Analog
Where is Lanreotide made?
4 companies sell it under their own name. Their labels name 3 factories in India, Greece and France.
India 1Greece 1France 1
Companies and their factories
| Company on the label | Factory | Where | Last FDA inspection |
|---|---|---|---|
| Amneal Pharmaceuticals LLC120 mg per 0.5 mL · NDC 70121-2517 | Amneal Pharmaceuticals Private LimitedMakes it, packages it and labels it | Ahmedabad, India | Not inspected on record |
| Cipla USA., Inc. Lanreotide Acetate60 mg per 0.2 mL, 90 mg per 0.3 mL, 120 mg per 0.5 mL · NDC 69097-870, 69097-906, 69097-880 +3 | Pharmathen International S.A.Makes it, tests it and packages it | Sapes, Greece | Serious problems, FDA actionNov 2025 |
| Exelan Pharmaceuticals, Inc.60 mg per 0.2 mL, 90 mg per 0.3 mL, 120 mg per 0.5 mL · NDC 76282-720, 76282-718, 76282-719 | Pharmathen International S.A.Makes it, tests it and packages it | Sapes, Greece | Serious problems, FDA actionNov 2025 |
| Ipsen Biopharmaceuticals, Inc. Somatuline Depot60 mg per 0.2 mL, 90 mg per 0.3 mL, 120 mg per 0.5 mL · NDC 15054-1120, 15054-1060, 15054-1090 | Ipsen Pharma BiotechMakes it | Signes, France | Problems found, fixed voluntarilyMar 2024 |
Recalls
- Mar 13, 2026 · Class II · Cipla USA, Inc. · 2 recall notices
Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure. - Jan 2, 2026 · Class II · Cipla USA, Inc.
Presence of Particulate Matter.
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.